NSEGeneral Updates3 Jul 2026 · 3 Jul 2026, 12:45 pm
General Updates
Marksans Pharma Limited · MARKSANS
✦ AI SummaryDividend
Marksans Pharma Limited has informed the Exchange about General Updates regarding Record Date 20 August 2026 for payment of dividend.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Limited has informed the Exchange about General Updates regarding Record Date 20 August 2026 for payment of dividend.
Attachments (1)
📄pdf
Download →
MARKSANS_03072026124531_SEIntimation.pdf
View document text
Date: July 03, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400001. Bandra (East), Mumbai - 400051.
Scrip Code: 524404 Symbol: MARKSANS
Sub: Outcome of Board Meeting
Dear Sir/Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and other regulations, if
applicable, please be informed that, the Board of Directors (“Board”) of the Company at its meeting
held today i.e. July 03, 2026 has, inter alia, considered and approved the following:
1. The 34th Annual General Meeting (“AGM”) of the Members of the Company will be held on
Thursday, 27 August 2026 at 11:00 a.m. (IST) through Video Conferencing (VC)/Other Audio
Visual Means (OAVM).
The Notice of AGM along with the Annual Report for FY 2026 will be sent through electronic
mode to those Members whose email addresses are registered with the Company/ Registrar
and Transfer Agent of the Company/ Depositories in due course, within the prescribed
timelines. The Notice of the AGM and the Annual Report will also be available on the
website of the Company and website of the Stock Exchanges, in due course.
2. The Company has fixed Thursday, 20 August 2026 as the Record Date for determining
eligibility of Members to receive final dividend for the financial year ended 31 March 2026.
The Board, at its meeting held on 26 May 2026, has recommended a final dividend of ₹
0.90/- (90%) per equity share of face value of ₹ 1/- each for the financial year ended 31
March 2026, subject to approval of Members of the Company at the ensuing AGM.
The final dividend, if approved at the AGM, will be paid, subject to deduction of tax at
source, on or after Thursday, 10 September 2026.
The meeting commenced at 11:15 a.m. and concluded at 11:50 a.m.
We request you to note the aforesaid in your records.
Thanking You,
Yours faithfully,
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary